SCHEMBL25513836

SCHEMBL25513836

C[C@@H]1COC[C@H]1c1cccc(Br)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 4/20 0.53
HTR2A P28223 5/20 0.46
HTR2C P28335 5/20 0.46
HTR2B P41595 5/20 0.46
RCOR1 Q9UKL0 1/20 0.40
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
HRH3 Q9Y5N1 5/20 0.37
ALDH1A1 P00352 1/20 0.36
MAPK1 P28482 1/20 0.36
DRD2 P14416 1/20 0.36
DRD1 P21728 1/20 0.36
DRD4 P21917 1/20 0.36
DRD5 P21918 1/20 0.36
DRD3 P35462 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
MEN1 O00255 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8329871 0.81 KDM1A (0.66) KDM1AHTR2AHTR2CHTR2BRCOR1
SCHEMBL15372957 0.81 KDM1A (0.66) KDM1AHTR2AHTR2CHTR2BRCOR1
SCHEMBL25497739 0.81 KDM1A (0.51) KDM1AHTR2AHTR2CHTR2BRCOR1
SCHEMBL25187274 0.81 KDM1A (0.51) KDM1AHTR2AHTR2CHTR2BRCOR1
SCHEMBL25183430 0.81 KDM1A (0.51) KDM1AHTR2AHTR2CHTR2BRCOR1
SCHEMBL1810741 0.77 KDM1A (0.50) KDM1AHTR2AHTR2CHTR2BRCOR1
SCHEMBL17029480 0.77 TSHR (0.44) KDM1AHTR2AHTR2CHTR2BRCOR1
SCHEMBL26176609 0.77 TSHR (0.44) KDM1AHTR2AHTR2CHTR2BRCOR1
SCHEMBL5019134 0.77 TSHR (0.44) KDM1AHTR2AHTR2CHTR2BRCOR1
SCHEMBL19775615 0.77 TSHR (0.44) KDM1AHTR2AHTR2CHTR2BRCOR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230149414-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230149414-A1 COMPOUNDS AND USES THEREOF VHL, CLN6, TFEB KDM1A 2149/4885HTR2A 3273/4885HTR2C 3674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.